A CRISPR antiviral tool

Emory scientists have adapted an antiviral enzyme from bacteria called Cas9 into an instrument for inhibiting hepatitis C virus in human cells.

Hepatitis C virus faces new weapon

In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.

Keeping oysters, clams and mussels safe to eat

Eating raw or undercooked mollusks may pose a safety hazard if they are harvested from waters polluted with pathogenic microbes, so U.S. Department of Agriculture (USDA) scientists are studying ways to enhance the food safety ...

Hepatitis B: Unusual virus discovered in shrews

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein ...

Toward explaining why hepatitis B hits men harder than women

Scientists in China are reporting discovery of unusual liver proteins, found only in males, that may help explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting men harder than ...

page 4 from 8